We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Innovative Method for Treating Sepsis

By HospiMedica International staff writers
Posted on 14 May 2012
A novel method for treating sepsis is based on margination, a natural phenomenon where bacteria and leukocytes move toward the endothelial lining of blood vessel walls.

Researchers at the Massachusetts Institute of Technology (MIT; Cambridge, USA) and the National University of Singapore have designed a branchlike system of microfluidic channels (20 µm high by 20 µm wide) etched onto a polymer chip, which mimic the marginizing action of vessels on bacteria and inflammatory cellular components such as leukocytes and platelets, in order to separate them from red blood cells (RBCs). More...
By using a simple cascaded channel design, the blood also undergoes a two-stage bacteria removal in a single pass through the device, thereby allowing higher bacterial removal efficiency.

“The developed technique offers significant advantages including high throughput and label-free separation, which allows nonspecific removal of any blood-borne pathogens,” concluded Han Wei Hou, PhD, of the MIT department of electrical engineering and computer science. “The continuous processing and collection mode could potentially enable the return of filtered blood back to the patient directly, similar to a simple and complete dialysis circuit setup.”
In an experiment with the prototype device, the researchers demonstrated highly efficient removal of the bacteria Escherichia coli (80%) and the yeast Saccharomyces cerevisiae (90%), as well as a greater than 80% depletion of inflammatory cellular components. The researchers also designed and tested a larger blood cleansing system, consisting of six microfluidic channel networks in parallel. They are also conducting a small-scale animal test to validate the efficacy of the technique in vivo.

Related Links:

Massachusetts Institute of Technology


National University of Singapore



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.